Southern Cross Acquisition II Sponsor Corp. and its sole shareholder Peizhong Yu filed Amendment No. 1 to a Schedule 13D with the SEC on November 4, 2026, disclosing beneficial ownership of 2,701,677 ordinary shares of Southern Cross Acquisition II Corp. following a partial forfeiture …
Southern Cross Acquisition II Sponsor Corp. and Peizhong Yu filed a Form 4 on November 4, 2026, disclosing the forfeiture of 324,123 ordinary shares of Southern Cross Acquisition II Corp. (NASDAQ:SCAT) on November 2, 2026, following the underwriter's partial exercise of its over-allotment option.
Natera, Inc. Chief Financial Officer Brophy Michael Burkes filed a Form 4 on November 4, 2026, disclosing three separate sales of Natera common stock totaling 795 shares on November 2 and 3, 2026, executed under Rule 10b5-1 plans.
Sergey Savchenko, Chief Financial Officer of Critical Metals Corp., filed a Form 4 on November 4, 2026, disclosing the sale of 66,667 ordinary shares on November 2, 2026.
Lauren Elaina Friedman Stat, a director of Palantir Technologies Inc., filed a Form 4 on November 4, 2026, disclosing a sale of 1,358 shares of Class A Common Stock on November 2, 2026, under a pre-established Rule 10b5-1 trading plan.
Steven Leonard Chapman, CEO and President of Natera, Inc., filed a Form 4 on November 4, 2026, disclosing three sales of Natera common stock totaling 3,801 shares on November 2, 2026, conducted under Rule 10b5-1 plans.
Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NASDAQ:NTRA), filed a Form 4 on November 4, 2026, disclosing the sale of 3,419 shares of common stock on November 2, 2026, under two separate Rule 10b5-1 arrangements.
John Fesko, President and Chief Business Officer of Natera, Inc. (NASDAQ:NTRA), filed a Form 4 on November 4, 2026, disclosing the sale of 302 shares of common stock on November 2, 2026, to satisfy tax withholding obligations connected to the vesting of restricted stock …
Daniel Rabinowitz, Secretary and Chief Legal Officer of Natera, Inc., filed a Form 4 on November 4, 2026, disclosing the sale of 341 shares of common stock on November 2, 2026, to satisfy tax withholding obligations related to vesting restricted stock units.
Matthew Rabinowitz, Executive Chairman of Natera, Inc., filed a Form 4 on November 4, 2026, disclosing two sales of Natera common stock on November 2, 2026, executed under a Rule 10b5-1 plan to cover tax withholding obligations tied to RSU vesting.